DSCSA compliance is only the beginning. Is your warehouse ready for the challenges it brings? Without the right strategies in place, compliance can create bottlenecks, delay shipments, and lead to costly disruptions. But with the right approach, it’s an opportunity to optimize your warehouse for long-term success. This playbook helps you turn compliance into a competitive edge. By adopting best practices beyond serialization and traceability, you can safeguard your operations, protect your reputation, and enhance patient safety.
Novartis narrowed its mid-term sales growth outlook to 5% annually through 2031 at its London investor day, as patent expirations weigh on the Swiss drugmaker.
As specialty drug complexity grows, agentic technology puts the right access, adherence, and affordability resources at the provider’s fingertips at prescribing.
Dr. Joe Geraci of NetraMark explains how AI analysis of clinical trial data can uncover hidden responder subgroups, separate true drug responders from placebo responders, and potentially rescue drug assets that appeared to fail in Phase II.
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.